Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Aporana AS
AS
Active
Org 983141838
Fridtjof Nansens Gate 21, 8622
Mo I Rana
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2001 · 25 years old
31 employees
Monitor
Share
Norway
/
Companies
/
Retail sale of pharmaceutical products
/
Aporana AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
111M
83M
55M
28M
0M
2021: 65M
65M
2021
2022: 68M (+5% vs 2021)
68M
+5%
2022
2023: 73M (+7% vs 2022)
73M
+7%
2023
2024: 84M (+15% vs 2023)
84M
+15%
2024
2025: 89M (+6% vs 2024)
89M
+6%
2025
EBITDA
NOK millions
7M
6M
4M
2M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 4M (+33% vs 2022)
4M
+33%
2023
2024: 6M (+50% vs 2023)
6M
+50%
2024
2025: 4M (-33% vs 2024)
4M
-33%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
89 433
83 568
72 590
68 354
65 291
Staff expenses
−17 555
−15 145
−13 438
−13 030
−12 477
EBITDA
4 327
5 507
4 262
3 415
3 449
Depreciation & amort.
−196
−226
−241
−291
−273
EBIT
4 131
5 281
4 021
3 124
3 176
Net financials
291
249
116
8
−9
Profit before tax
4 423
5 529
4 136
3 131
3 167
Tax
973
1 217
911
704
697
Net profit
3 450
4 312
3 226
2 427
2 470
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
16 207
17 466
19 787
14 036
13 760
Equity
3 614
164
164
165
165
Long-term debt
0
32
34
46
60
Short-term debt
12 561
17 269
19 589
13 825
13 536
Total debt
12 593
17 302
19 623
13 871
13 596
Financial ratios
5-year trend
EBITDA margin
4,8 %
This company
15,8 %
Market median
This company
Market median
70% below market
2021
2025
Equity ratio
22,3 %
This company
38,2 %
Market median
This company
Market median
42% below market
2021
2025
Return on equity
95,5 %
This company
18,4 %
Market median
This company
Market median
419% above market
2021
2025
Net profit margin
3,9 %
This company
8,1 %
Market median
This company
Market median
52% below market
2021
2025
Asset turnover
5,52×
This company
1,12×
Market median
This company
Market median
393% above market
2021
2025
Debt / equity
3,49×
This company
0,62×
Market median
This company
Market median
463% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Aporana AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
